arXiv Quantitative Biology @arxiv_bio@qoto.org

The first 100 days: modeling the evolution of the COVID-19 pandemic. (arXiv:2004.14664v1 [q-bio.PE]) http://arxiv.org/abs/2004.14664

Containment effort reduction and regrowth patterns of the Covid-19 spreading. (arXiv:2004.14701v1 [q-bio.PE]) http://arxiv.org/abs/2004.14701

How Often Should People be Tested for Corona to Avoid a Shutdown?. (arXiv:2004.14767v1 [q-bio.PE]) http://arxiv.org/abs/2004.14767

Refined compartmental models, asymptomatic carriers and COVID-19. (arXiv:2004.14780v1 [q-bio.PE]) http://arxiv.org/abs/2004.14780

Modelling the role of media induced fear conditioning in mitigating post-lockdown COVID-19 pandemic: perspectives on India. (arXiv:2004.13777v1 [q-bio.PE]) http://arxiv.org/abs/2004.13777

Analysis of ensemble feature selection for correlated high-dimensional RNA-Seq cancer data. (arXiv:2004.13809v1 [q-bio.GN]) http://arxiv.org/abs/2004.13809

Decoding SARS-CoV-2 transmission, evolution and ramification on COVID-19 diagnosis, vaccine, and medicine. (arXiv:2004.14114v1 [q-bio.GN]) http://arxiv.org/abs/2004.14114

Dynamics of an imprecise stochastic multimolecular biochemical reaction model with L\'{e}vy jumps. (arXiv:2004.14163v1 [math.PR]) http://arxiv.org/abs/2004.14163

Interstitial cells and neurons respond to variations in hydration. (arXiv:2004.14290v1 [q-bio.TO]) http://arxiv.org/abs/2004.14290

CAR T cells for T-cell leukemias: Insights from mathematical models. (arXiv:2004.14291v1 [q-bio.TO]) http://arxiv.org/abs/2004.14291

Therapeutic Management of Sacro-coccygeal compression in a Green Iguana (Iguana iguana). (arXiv:2004.14296v1 [q-bio.TO]) http://arxiv.org/abs/2004.14296

The energy of muscle contraction. II. Transverse compression and work. (arXiv:2004.14297v1 [q-bio.TO]) http://arxiv.org/abs/2004.14297

A New Physically Triggered Cell Death via Transbarrier Contactless Cold Atmospheric Plasma Treatment of Cancer Cells. (arXiv:2004.14298v1 [q-bio.TO]) http://arxiv.org/abs/2004.14298

Using smartphones and wearable devices to monitor behavioural changes during COVID-19. (arXiv:2004.14331v1 [q-bio.QM]) http://arxiv.org/abs/2004.14331

Second waves, social distancing, and the spread of COVID-19 across America. (arXiv:2004.13017v1 [q-bio.PE]) http://arxiv.org/abs/2004.13017

Size and timescale of epidemics in the SIR framework. (arXiv:2004.13024v1 [q-bio.PE]) http://arxiv.org/abs/2004.13024

Application of Deep Interpolation Network for Clustering of Physiologic Time Series. (arXiv:2004.13066v1 [cs.LG]) http://arxiv.org/abs/2004.13066

Control with uncertain data of socially structured compartmental epidemic models. (arXiv:2004.13067v1 [q-bio.PE]) http://arxiv.org/abs/2004.13067

PARCE: Protocol for Amino acid Refinement through Computational Evolution. (arXiv:2004.13119v1 [q-bio.BM]) http://arxiv.org/abs/2004.13119

Energy-based models for atomic-resolution protein conformations. (arXiv:2004.13167v1 [cs.LG]) http://arxiv.org/abs/2004.13167